Tuxiong Huang

1.0k total citations
18 papers, 742 citations indexed

About

Tuxiong Huang is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Tuxiong Huang has authored 18 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Immunology and 5 papers in Infectious Diseases. Recurrent topics in Tuxiong Huang's work include Viral gastroenteritis research and epidemiology (5 papers), Clostridium difficile and Clostridium perfringens research (5 papers) and Epigenetics and DNA Methylation (5 papers). Tuxiong Huang is often cited by papers focused on Viral gastroenteritis research and epidemiology (5 papers), Clostridium difficile and Clostridium perfringens research (5 papers) and Epigenetics and DNA Methylation (5 papers). Tuxiong Huang collaborates with scholars based in China, United States and Hong Kong. Tuxiong Huang's co-authors include Li Fu, Xin‐Yuan Guan, Chang Zou, Hanping Feng, Xiangyu Tan, Gregorio Pérez‐Cordón, Beilei Liu, Shan Li, Yuting Li and Zhe Chen and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Tuxiong Huang

17 papers receiving 737 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tuxiong Huang China 13 299 274 233 171 144 18 742
Haijing Deng China 15 334 1.1× 227 0.8× 179 0.8× 95 0.6× 233 1.6× 19 994
Thomas J. Hayman United States 13 375 1.3× 169 0.6× 265 1.1× 63 0.4× 99 0.7× 27 667
Martina Di Modica Italy 12 588 2.0× 444 1.6× 249 1.1× 81 0.5× 189 1.3× 15 972
Lai Xue United States 10 279 0.9× 213 0.8× 86 0.4× 74 0.4× 62 0.4× 13 579
Zhigao Xu China 15 791 2.6× 253 0.9× 240 1.0× 118 0.7× 424 2.9× 23 1.2k
Maha Zohra Ladjemi France 15 262 0.9× 180 0.7× 256 1.1× 76 0.4× 42 0.3× 24 835
Kotaro Miyake Japan 14 342 1.1× 328 1.2× 205 0.9× 37 0.2× 132 0.9× 59 864
Chang Song China 9 292 1.0× 210 0.8× 299 1.3× 129 0.8× 59 0.4× 25 665
Nianli Liu China 16 401 1.3× 117 0.4× 181 0.8× 52 0.3× 188 1.3× 33 714

Countries citing papers authored by Tuxiong Huang

Since Specialization
Citations

This map shows the geographic impact of Tuxiong Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuxiong Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuxiong Huang more than expected).

Fields of papers citing papers by Tuxiong Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tuxiong Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuxiong Huang. The network helps show where Tuxiong Huang may publish in the future.

Co-authorship network of co-authors of Tuxiong Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Tuxiong Huang. A scholar is included among the top collaborators of Tuxiong Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tuxiong Huang. Tuxiong Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zhang, Tiantian, Qian Lin, Tuxiong Huang, et al.. (2024). WNT2 blockade augments antitumor immunity by attenuating myeloid‐derived suppressor cells in colorectal cancer. SHILAP Revista de lepidopterología. 3(4).
2.
Tan, Xiangyu, Yuting Li, Huahui Li, et al.. (2023). WNT2–SOX4 positive feedback loop promotes chemoresistance and tumorigenesis by inducing stem-cell like properties in gastric cancer. Oncogene. 42(41). 3062–3074. 23 indexed citations
3.
Pan, Juan, Tuxiong Huang, Zhenjun Deng, & Chang Zou. (2023). Roles and therapeutic implications of m6A modification in cancer immunotherapy. Frontiers in Immunology. 14. 1132601–1132601. 25 indexed citations
4.
Dong, Shaowei, Jian Wang, Tuxiong Huang, et al.. (2023). NOTCH4ΔL12_16 sensitizes lung adenocarcinomas to EGFR-TKIs through transcriptional down-regulation of HES1. Nature Communications. 14(1). 3183–3183. 6 indexed citations
5.
Su, Zhenwei, Shaowei Dong, Yao Chen, et al.. (2023). Microfluidics‐Enabled Nanovesicle Delivers CD47/PD‐L1 Antibodies to Enhance Antitumor Immunity and Reduce Immunotoxicity in Lung Adenocarcinoma. Advanced Science. 10(20). e2206213–e2206213. 26 indexed citations
6.
Zhang, Ying, Tiantian Zhang, Lin Gao, et al.. (2022). Downregulation of MTAP promotes Tumor Growth and Metastasis by regulating ODC Activity in Breast Cancer. International Journal of Biological Sciences. 18(7). 3034–3047. 14 indexed citations
7.
Liu, Beilei, Xiaona Fang, Dora Lai‐Wan Kwong, et al.. (2022). Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 41(1). 182–182. 27 indexed citations
8.
Huang, Tuxiong, Xiangyu Tan, Yuting Li, et al.. (2021). Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity. Gut. 71(2). 333–344. 142 indexed citations
9.
Li, Huahui, Yuting Li, Ying Zhang, et al.. (2021). MAPK10 Expression as a Prognostic Marker of the Immunosuppressive Tumor Microenvironment in Human Hepatocellular Carcinoma. Frontiers in Oncology. 11. 687371–687371. 7 indexed citations
10.
Fu, Yu‐Fei, Qi Zheng, Yingying Mao, et al.. (2020). WNT2-Mediated FZD2 Stabilization Regulates Esophageal Cancer Metastasis via STAT3 Signaling. Frontiers in Oncology. 10. 1168–1168. 18 indexed citations
11.
Huang, Tuxiong & Li Fu. (2019). The immune landscape of esophageal cancer. Cancer Communications. 39(1). 79–79. 166 indexed citations
12.
Huang, Tuxiong, Xin‐Yuan Guan, & Li Fu. (2019). Therapeutic targeting of the crosstalk between cancer-associated fibroblasts and cancer stem cells.. PubMed. 9(9). 1889–1904. 71 indexed citations
13.
Huang, Tuxiong, Gregorio Pérez‐Cordón, Lianfa Shi, et al.. (2015). Clostridium difficile toxin B intoxicated mouse colonic epithelial CT26 cells stimulate the activation of dendritic cells. Pathogens and Disease. 73(3). 7 indexed citations
14.
Yang, Zhiyong, Yongrong Zhang, Tuxiong Huang, & Hanping Feng. (2015). Glucosyltransferase activity ofClostridium difficileToxin B is essential for disease pathogenesis. Gut Microbes. 6(4). 221–224. 16 indexed citations
15.
Yuan, Pengfei, Hongmin Zhang, Shiyou Zhu, et al.. (2014). Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B. Cell Research. 25(2). 157–168. 141 indexed citations
16.
Li, Shan, Lianfa Shi, Zhiyong Yang, et al.. (2014). Critical Roles of Clostridium difficile Toxin B Enzymatic Activities in Pathogenesis. Infection and Immunity. 83(2). 502–513. 27 indexed citations
17.
Huang, Tuxiong, Shan Li, Guangchao Li, et al.. (2014). Utility of Clostridium difficile Toxin B for Inducing Anti-Tumor Immunity. PLoS ONE. 9(10). e110826–e110826. 19 indexed citations
18.
Li, Qiang, et al.. (2012). Biochemical characterization of human peroxiredoxin 2, an antioxidative protein. Acta Biochimica et Biophysica Sinica. 44(9). 759–764. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026